AFJK
NASDAQAimei Health Technology Co. Ltd
IPO2024
Aimei Health Technology Co. Ltd (AFJK) is a public company listed on NASDAQ. In the last 30 days Quantisnow tracked 4 wire items for AFJK, including 4 SEC filings. The most recent was published Nov 5, 2026.
News · 26 weeks20+50%
2026-05-102026-11-01
Mix990d
- SEC Filings8(89%)
- Other1(11%)
Latest news
25 items- SECAimei Health Technology Co. Ltd filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECAmendment: Aimei Health Technology Co. Ltd filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K/A - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECSEC Form DEF 14A filed by Aimei Health Technology Co. LtdDEF 14A - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECSEC Form PRE 14A filed by Aimei Health Technology Co. LtdPRE 14A - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECSEC Form 8-K filed by Aimei Health Technology Co. Ltd8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECAimei Health Technology Co. Ltd filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECAimei Health Technology Co. Ltd filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECSEC Form 10-Q filed by Aimei Health Technology Co. Ltd10-Q - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Aimei Health Technology Co. LtdSCHEDULE 13G/A - Aimei Health Technology Co., Ltd. (0001979005) (Subject)
- SECAimei Health Technology Co. Ltd filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Aimei Health Technology Co. LtdSCHEDULE 13G/A - Aimei Health Technology Co., Ltd. (0001979005) (Subject)
- SECAimei Health Technology Co. Ltd filed SEC Form 8-K: Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- PRAIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.Aimei Health Technology Co., Ltd. Announces Termination of Business Combination Agreement NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (NASDAQ:AFJK, AFJKU, AFJKR, the "Company")) announced today that it has terminated the Business Combination Agreement, dated as of June 19, 2024, as amended on June 6, 2025, with United Hydrogen Group Inc. ("United Hydrogen") and the other parties thereto. The Company delivered a notice of termination to United Hydrogen on July 7, 2026, pursuant to Section 9.1(b) of the Business Combination Agreement, effective immediately. The termination was triggered by the occurrence of the applicable outside date, as the closing of the
- SECAimei Health Technology Co. Ltd filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- INSIDERSEC Form 3 filed by new insider Polvi Daniel Veikko3 - Aimei Health Technology Co., Ltd. (0001979005) (Issuer)
- SECAimei Health Technology Co. Ltd filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECSEC Form 10-Q filed by Aimei Health Technology Co. Ltd10-Q - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECAimei Health Technology Co. Ltd filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECAimei Health Technology Co. Ltd filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- PRAIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED QUARTERLY REPORTNew York, NY, May 20, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (the "Company") (NASDAQ:AFJK) today announced that on May 19, 2026, it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of the Company's delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the "Quarterly Report") with the U.S. Securities and Exchange Commission (the "SEC"), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"). The Quarterly Report was due on May 15, 2026. The Notice has no immediate
- SECAimei Health Technology Co. Ltd filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECSEC Form 10-K filed by Aimei Health Technology Co. Ltd10-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- SECAimei Health Technology Co. Ltd filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
- PRAIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED ANNUAL REPORTNew York, NY, April 21, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (the "Company") (NASDAQ:AFJK) today announced that on April 17, 2026, it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of the Company's delay in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the "Annual Report") with the U.S. Securities and Exchange Commission (the "SEC"), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"). The Annual Report was due on March 31, 2026, and the Company filed a
- SECAimei Health Technology Co. Ltd filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
AFJK FAQ
4 questionsWhat is the latest news on AFJK?
In the last 30 days Quantisnow tracked 4 wire items for AFJK: 4 SEC filings. The most recent was published on November 5, 2026.Where does AFJK stock trade?
Aimei Health Technology Co. Ltd (AFJK) is listed on NASDAQ.When did Aimei Health Technology Co. Ltd go public?
Aimei Health Technology Co. Ltd (AFJK) completed its IPO in 2024.How can I track AFJK on Quantisnow?
Quantisnow aggregates Aimei Health Technology Co. Ltd's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AFJK to receive live email and push alerts on every new disclosure.